Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,110.00    10.00 (0.91%)
Bid:
1,090.00
Ask:
1,130.00
Spread: 40.00 (3.67%)
Market Cap: £327.90m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Full Year Trading Update

23 Oct 2025 07:00

RNS Number : 4223E
Cerillion PLC
23 October 2025
 

AIM: CER

 

 Cerillion plc

("Cerillion" or "the Company")

 

Full Year Trading Update

 

Cerillion, the billing, charging and customer relationship management software solutions provider, is pleased to announce an update on trading for the financial year ended 30 September 2025.

 

The Company traded well over the second half of its financial year, securing two major follow-on contracts, with an existing European customer in September 2025, after signing a major new services agreement with that customer in May 2025. At a combined £25.3 million over five years, they are amongst Cerillion's largest contract wins.

 

The wins helped to take total new orders signed in the financial year to a record high of £47.6m, 25% higher than the prior year. It reflects both new customer additions and the growing value of the installed base. Revenue for the financial year is expected to be approximately £45.3m (2024: £43.8m), reflecting the timing of contract wins, and adjusted profit before tax is expected to be slightly ahead of the consensus market forecast of £20.5m (2024: adjusted profit before tax of £19.8m). The balance sheet remains very strong, with net cash at the financial year-end increased to £34.4m (30 September 2024: £29.9m).

 

The Company enters the new financial year with both a strong back-order book* and a very strong sales pipeline, which includes some substantial opportunities. The Board therefore continues to view growth prospects very positively.

 

Notice of Results

Full year results are expected to be reported in late November 2025, when the Company will also provide a further update on current trading. 

 

*Back-order book consists of sales contracted but not yet recognised as revenue at the end of the reporting period plus annualised support and maintenance revenue.

Enquiries:

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Andrew Dickson, CFO

Panmure Liberum (Nomad and Broker)

T: 020 3100 2000

Bidhi Bhoma, Edward Mansfield, Shalin Bhamra, Freddie Wooding

Singer Capital Markets (Joint Broker)

T: 020 7496 3000

Rick Thompson, James Fischer

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Robert Morton

 

About Cerillion

www.cerillion.com

 

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management ("CRM"), mainly serving the telecommunications market but also other sectors such as utilities and financial services. The Company currently has c.70 customer installations across c.45 countries. Headquartered in London, Cerillion also has operations in India and Bulgaria, as well as sales presence in continental Europe, the USA, Singapore and Australia.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZMZGMZGGKZM
Date   Source Headline
14th Feb 20079:32 amRNSDirectorate Change
31st Jan 20077:01 amRNSRe Joint Venture
29th Jan 20074:00 pmRNSDirector/PDMR Shareholding
2nd Jan 20079:56 amRNSEPT Disclosure
28th Dec 20062:20 pmRNSTotal Voting Rights
28th Dec 200612:29 pmRNSAdditional Listing
27th Dec 20068:46 amRNSEPT Disclosure
22nd Dec 200612:34 pmRNSCeltic Resources Holdings plc
22nd Dec 200610:42 amRNSScheme of arrangement
22nd Dec 20068:01 amRNSEPT Disclosure
21st Dec 20065:21 pmRNSDirector/PDMR Shareholding
21st Dec 20065:19 pmRNSAdditional Listing
21st Dec 20062:32 pmRNSDirectorate Change
21st Dec 200611:26 amRNSEPT Disclosure
20th Dec 20063:46 pmRNSAcquisition
20th Dec 20063:20 pmRNSResult of Court Hearing
20th Dec 20067:01 amRNSUpdate re. Arduina
19th Dec 20068:16 amRNSEPT Disclosure
15th Dec 200611:40 amRNSEPT Disclosure
14th Dec 200611:12 amRNSEPT Disclosure
13th Dec 20069:12 amRNSEPT Disclosure
7th Dec 200610:27 amRNSEPT Disclosure
5th Dec 200610:48 amRNSEPT Disclosure
4th Dec 200610:46 amRNSEPT Disclosure
1st Dec 200610:28 amRNSEPT Disclosure
30th Nov 20061:40 pmRNSResult of EGM
30th Nov 200610:25 amRNSEPT Disclosure
29th Nov 200610:21 amRNSEPT Disclosure
27th Nov 200611:35 amRNSEPT Disclosure
24th Nov 20069:20 amRNSEPT Disclosure
23rd Nov 200611:54 amRNSEPT Disclosure
22nd Nov 20067:02 amRNSSale of Olympias Concentrates
22nd Nov 20067:01 amRNSConcentrate Purchase
21st Nov 200610:02 amRNSEPT Disclosure
20th Nov 200610:45 amRNSEPT Disclosure
14th Nov 20069:40 amRNSEPT Disclosure
10th Nov 20069:32 amRNSEPT Disclosure
9th Nov 200611:21 amRNSEPT Disclosure
7th Nov 200610:07 amRNSEPT Disclosure
7th Nov 20067:02 amRNSTrading Update
7th Nov 20067:02 amRNSOffer by Celtic Resources
6th Nov 20069:01 amRNSEPT Disclosure
6th Nov 20067:43 amRNSOffer Update
6th Nov 20067:01 amRNSHolding(s) in Company
3rd Nov 20064:51 pmRNSEPT Disclosure - Replacement
3rd Nov 200610:03 amRNSEPT Disclosure
2nd Nov 200610:21 amRNSEPT Disclosure
1st Nov 200610:19 amRNSEPT Disclosure
31st Oct 200611:28 amRNSEPT Disclosure
26th Oct 200610:35 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.